Drugs / muJ591
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00006380 | Sep 2000 → Mar 2002 | prostate cancer | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
| Phase 1 | NCT00003391 | Jun 1998 → ? | prostate cancer | Weill Medical College of Cornell University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | muJ591 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00006380 ↗ |
| Modality | Monoclonal antibody | “monoclonal antibody muJ591” NCT00003391 ↗ |
| Route | Intravenous | “single dose of intravenous iodine I 131-labeled monoclonal antibody muJ591” NCT00003391 ↗ |